 Bronstein, Gewirtz Grossman, LLC notifies investors that a class action lawsuit has been filed against MEI Pharma, Inc. MEI Pharma or the Company NASDAQ: MEIP and certain of its officers, on behalf of shareholders who purchased or otherwise acquired MEI Pharma securities in the U.S. between August 2, 2017 and July 1, 2020, both dates inclusive the Class Period. Such investors are encouraged to join this case by visiting the firms site: 